Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oyster Point Pharma Inc.

    NASDAQ: OYST · Real-Time Price · USD
    11.17
    0.00 (0.00%)
    At close: Dec 30, 2022, 10:00 PM

    Oyster Point Pharma Statistics

    Share Statistics

    Oyster Point Pharma has 0 shares outstanding. The number of shares has increased by 2.66% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 2.66%

    Shares Change (QoQ)

    n/a
    		 1.93%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 8.83M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -4.55 and the forward PE ratio is null. Oyster Point Pharma's PEG ratio is -0.12.

    PE Ratio

    n/a
    		 -4.55

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 19.38

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 4.78

    P/FCF Ratio

    n/a
    		 -5.23

    PEG Ratio

    n/a
    		 -0.12
    Financial Ratio History

    Enterprise Valuation

    Oyster Point Pharma has an Enterprise Value (EV) of 374.81M.

    EV / Sales

    n/a
    		 15.27

    EV / EBITDA

    n/a
    		 -3.87

    EV / EBIT

    n/a
    		 -4.19

    EV / FCF

    n/a
    		 -4.13

    Financial Position

    The company has a current ratio of 7.47, with a Debt / Equity ratio of 0.93.

    Current Ratio

    n/a
    		 7.47

    Quick Ratio

    n/a
    		 7.26

    Debt / Equity

    n/a
    		 0.93

    Debt / EBITDA

    n/a
    		 -0.96

    Debt / FCF

    n/a
    		 -1.02

    Interest Coverage

    n/a
    		 -25.96

    Financial Efficiency

    Return on Equity is -104.88% and Return on Invested Capital is -52.28%.

    Return on Equity

    n/a
    		 -104.88%

    Return on Assets

    n/a
    		 -46.89%

    Return on Invested Capital

    n/a
    		 -52.28%

    Revenue Per Employee

    n/a
    		 $80,986.8

    Profits Per Employee

    n/a
    		 $-344,531.35

    Employee Count

    n/a
    		 303

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 0.25

    Taxes

    Income Tax

    n/a
    		 3.73M

    Effective Tax Rate

    n/a
    		 -3.71%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Oyster Point Pharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 10.42

    200-Day Moving Average

    n/a
    		 7.48

    Relative Strength Index (RSI)

    n/a
    		 65.49

    Average Volume (20 Days)

    n/a
    		 417,562

    Income Statement

    In the last 12 months, Oyster Point Pharma had revenue of 24.54M and earned -104.39M in profits. Earnings per share was -4.01.

    Revenue

    n/a
    		 24.54M

    Gross Profit

    n/a
    		 23.01M

    Operating Income

    n/a
    		 -96.92M

    Net Income

    n/a
    		 -104.39M

    EBITDA

    n/a
    		 -96.78M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -4.01
    Full Income Statement

    Balance Sheet

    The company has 193.37M in cash and 92.73M in debt, giving a net cash position of 100.64M.

    Cash & Cash Equivalents

    n/a
    		 193.37M

    Total Debt

    n/a
    		 92.73M

    Net Cash

    n/a
    		 100.64M

    Retained Earnings

    n/a
    		 -255.41M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -89.37M and capital expenditures -1.49M, giving a free cash flow of -90.86M.

    Operating Cash Flow

    n/a
    		 -89.37M

    Capital Expenditures

    n/a
    		 -1.49M

    Free Cash Flow

    n/a
    		 -90.86M

    FCF Per Share

    n/a
    		 -3.49
    Full Cash Flow Statement

    Margins

    Gross margin is 93.79%, with operating and profit margins of -394.98% and -425.42%.

    Gross Margin

    n/a
    		 93.79%

    Operating Margin

    n/a
    		 -394.98%

    Pretax Margin

    n/a
    		 -410.2%

    Profit Margin

    n/a
    		 -425.42%

    EBITDA Margin

    n/a
    		 -394.41%

    EBIT Margin

    n/a
    		 -394.98%

    FCF Margin

    n/a
    		 -370.25%

    Dividends & Yields

    OYST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -21.96%

    FCF Yield

    n/a
    		 -19.11%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for OYST.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist